TMC Life Sciences Berhad, an investment holding company, provides healthcare services in Malaysia. The company operates Thomson Hospital Kota Damansara (THKD), a 559-bedded medical center located in Selangor. Its THKD provides orthopedics, ENT, head and neck laser, women and children, fertility, dietetic, and accident and emergency services. The company's fertility center offers time lapse imaging, preimplantation genetic testing, fertility genecode, and other services. It also offers fertility consultancy services; laboratory and embryology; traditional and complementary; pharmacy services and products; and management support and multi-disciplinary tertiary care services. In addition, the company operates a women's clinic and fertility centers, as well as provides related services; develops, markets, and manages healthcare programs; and operates pharmacy store. Further, it engages in the research and development activities; and property investment activities. The company was founded in 1994 and is based in Petaling Jaya, Malaysia. TMC Life Sciences Berhad is a subsidiary of Sasteria (M) Pte. Ltd.
Stock data | 2023 | Change |
---|---|---|
Price | $0.10986571967595163 | N/A |
Market Cap | $191.37M | N/A |
Shares Outstanding | 1.74B | 0.00% |
Employees | 0 | N/A |
Shareholder Equity | 861.96M | 4.18% |
Valuation | 2023 | Change |
---|---|---|
P/E Ratio | 4.88 | N/A |
P/S Ratio | 2.77 | N/A |
P/B Ratio | 0.22 | N/A |
Growth | 2023 | Change |
---|---|---|
Return on Equity | 0.0101 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $69.13M | N/A |
Earnings | $8.71M | N/A |
EPS | 0.0225 | N/A |
Earnings Yield | 0.2048 | N/A |
Gross Margin | 0.7107 | N/A |
Operating Margin | 0.1379 | N/A |
Net income margin | 0.126 | N/A |
Financial Strength | 2023 | Change |
---|---|---|
Total Assets | $261.19M | N/A |
Total Debt | $48.62M | N/A |
Cash on Hand | $36.04M | N/A |
Debt to Equity | 0.0811 | -1.07% |
Cash to Debt | 0.7413 | 12.33% |
Current Ratio | $2.55 | 12.75% |